Viatris Inc. (VTRS) will raise its dividend by 9.1 percent to 12 cents per share in 2022. Last year the pharmaceutical company started paying a quarterly dividend of 11 cents per share.
The new annual dividend of $0.48 per share for VTRS yields approximately 3.3% at a stock price of $14.50 for VTRS. The dividend will be payable on March 16, 2022 to shareholders of record at the close of business on February 24, 2022.
"We have been pleased with our strong underlying business performance and operational momentum and remain committed to returning capital to shareholders," said Michael Goettler, Chief Executive Officer of Viatris.
Viatris Inc., formerly Upjohn Inc., is a healthcare company. Viatris is specialized in delivering medicines to patients in countries and territories worldwide. It provides access to medicines, advance sustainable operations, develop solutions and leverage it's specializatiin to connect people to products and services through it's Global Healthcare Gateway. The company's portfolio comprises of more than 1,400 molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, global brands, complex generic and branded medicines, portfolio of biosimilars and a variety of over-the-counter consumer products. It produces medicines for patients across a broad range of therapeutic areas, spanning both noncommunicable and infectious diseases, which include cardiovascular, oncology, immunology, women’s healthcare, diabetes and metabolism, gastroenterology, respiratory and allergy and dermatology. Viatris initiated a quarterly dividend in 2021.